Biotech

All Articles

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Therapy was actually wowed enough with Harbour BioMed's bispecific immune system activator...

A more detailed look at Intense Biotech's Fierce 15

.Within this full week's episode of "The Best Pipe," our team're diving into Intense Biotech's yearl...

Lilly encounters period 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's celebration commemorating the approval of Alzh...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Accept to today's Chutes &amp Ladders, our summary of considerable management hirings, firings as w...

Lykos will ask FDA to reassess its own decision observing rejection of MDMA treatment for post-traumatic stress disorder

.Adhering to a bad presenting for Lykos Therapies' MDMA candidate for trauma at a current FDA consul...

AN 2 fifty percents roll call, ceases phase 3 trial after records disappoint

.AN2 Therapeutics is rethinking its own service in action to uninspired midphase records, promising ...

Merck pays for $700M for bispecific, snooping autoimmune position and possibility to challenge Amgen in cancer cells

.Merck &amp Co. is paying out $700 million beforehand to challenge Amgen in a blood stream cancer ce...

Gilead pays J&ampJ $320M to exit licensing deal for seladelpar

.With Gilead Sciences on the verge of an FDA choice for its own liver condition drug seladelpar, the...

' All palms on deck' at Lilly as peers target being overweight market

.CEO David Ricks can observe the providers putting together outdoors tents at basecamp responsible f...

Entero giving up staff, abandoning office and also pausing R&ampD

.Cushion Liquidators has actually turned Entero Rehabs white as a sheet. The creditor bought Entero ...